Fisher & Paykel Healthcare August 2020 ASM

Fisher & Paykel Healthcare (FPH) is a leading provider of products and systems used in respiratory care, acute care, surgery and treatment of obstructive sleep apnoea. We wrote previously about the company’s leading environmental, social and governance initiatives, including appropriate remuneration policies, equal hiring policies and innovative and thoughtful environmental policies.

As a New Zealand based company, they presented their 12-month financial performance to 31 March 2020 on the 29th June. In June, FPH highlighted the significant increase in demand for its hospital respiratory care products due to COVID-19 and in August at the Annual Shareholder Meeting (ASM) confirmed that the trend had continued, and demand for hospital products had increased 91% in the first 4 months of the financial year (April, May, June and July). We continue to believe that the company has the leading respiratory-care system and is incredibly well run by a dedicated team.

This note has been prepared by ELM Responsible Investments (‘ELMRI’) ABN 70 607 177 711 AFSL 520428, for Australian wholesale clients for the purposes of section 761G of the Corporations Act 2001 (Cth).

The information is not intended for general distribution or publication and must be retained in a confidential manner. Information contained herein consists of confidential proprietary information constituting the sole property of ELMRI and its investment activities; its use is restricted accordingly.

This note is for general informational purposes only and does not purport to be comprehensive or to give advice. The views expressed are the views of the writer at the time of preparation and presenting and all forecasts, assumptions, opinions, data and other information are not warranted as to accuracy or completeness and are subject to change without notice. This is not an offer document and does not constitute an offer or invitation of investment recommendation to distribute or purchase securities, shares, units or other interests to enter into an investment agreement. No person should rely on the content and/or act on the basis of any material contained in this note. Any potential investor should consider their own circumstances and seek professional advice.

ELMRI funds, its directors, employees, representatives and associates may have an interest in the named securities.

Past performance is for illustrative purposes only and is not indicative of future performance.